DBV Technologies' epicutaneous immunotherapy tested using NativeSkin® ex vivo human skin Latest results to be presented at the AAAAI/WAO Joint Congress in Orlando The poster "Epicutaneous immunotherapy with peanut directly targets Langerhans cells in human skin" (n° 723, session 4204) will be presented at the American Academy of Allergy, Asthma & Immunology (AAAAI)/World Allergy Organization (WAO) Joint Congress in Orlando, Florida on
Read more